NL-OMON49545招募中不适用
[89Zr]Df-IAB22M2C anti-CD8 minibody PET/CT imaging to assess the in vivo distribution of CD8+ T-cells in COVID-19 patients. - PET/CT imaging to track CD8+ T-cells in COVID-19 patients.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All patients must meet all of the following criteria:
- •1. microbiologically proven SARS-CoV-19 infection;
- •2. More than or equal to 18 years of age;
- •3. Ability to provide written informed consent.
排除标准
- •A patient will be excluded from participation in the trial if one or more of
- •the following criteria are met:
- •1. Contra-indication for PET; pregnancy, breast-feeding, severe claustrophobia
- •2. Contra-indication for administration of iodine-containing contrast agents
- •3. Other serious illness, e.g. history of malignancies or auto-immune disorders
- •4. Known pre-existing lymphopenia from an unrelated other medical condition
- •5. Estimated creatinine clearance <= 30mL/min according to the Cockcroft-Gault
- •formula (or local institutional standard method) OR oligo-uric patients
- •(<400mL/24hr)
研究者
相似试验
进行中（未招募）
1 期
PET/CT imaging to track CD8+ T-cells in COVID-19 patients.EUCTR2020-005984-29-NLRadboud University Medical Center20
终止
不适用
CD8+ T-cell PET/CT Imaging in COVID-19 PatientsLymphopenia Due to COVID-19T-cellPET ImagingNCT04874818Radboud University Medical Center5
招募中
3 期
CD8 PET imaging study before and after CAR T-cell therapy2025-520560-18-00Universitair Medisch Centrum Groningen27
招募中
2 期
A phase 2 immunoPET imaging study with ZED88082A/CED88004S in patients with Large B-cell lymphoma before and after CD19-directed CAR T-cell therapyLarge B-cell lymphoma10025320lymphomaNL-OMON51886niversitair Medisch Centrum Groningen23
进行中（未招募）
1 期
Imaging of inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis with a PET/CT scan.rheumatoid arthritis, giant cell arteritisCTIS2024-514489-38-01niversitair Medisch Centrum Groningen20